ArticleCurrent microbiology2013
Salicylate degradation by the fungal plant pathogen Sclerotinia sclerotiorum.
Article in Current microbiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 33 citations in OpenAlex.
- An Updated Perspective on the Aromatic Metabolic Pathways of Plant-Derived Homocyclic Aromatic Compounds inMicroorganisms · 2025Review
- ChnagG Plays the Role of 5-Salicylate Hydroxylase in the Gentisic Acid Pathway of Salicylic Acid Metabolism in Cochliobolus heterostrophus.Molecular plant pathology · 2025Article
- Global mRNA profiling reveals the effect of boron as a crop protection tool againstAoB PLANTS · 2024Article
- Concentration-dependent effect of plant secondary metabolites on bacterial and fungal microbiomes in caterpillar guts.Microbiology spectrum · 2024Article
- The nuclear effector MoHTR3 of Magnaporthe oryzae modulates host defence signalling in the biotrophic stage of rice infection.Molecular plant pathology · 2023Article
- Lignin-Modifying Enzymes inJournal of fungi (Basel, Switzerland) · 2023Article
- Genome sequence of Monilinia vaccinii-corymbosi sheds light on mummy berry disease infection of blueberry and mating type.G3 (Bethesda, Md.) · 2021Article
- Lower Funneling Pathways inFrontiers in microbiology · 2021Article
- Gene regulation of Sclerotinia sclerotiorum during infection of Glycine max: on the road to pathogenesis.BMC genomics · 2019Article
- Salicylic acid as an effective elicitor for improved taxol production in endophytic fungus Pestalotiopsis microspora.PloS one · 2019Article
- Characterization of aFrontiers in microbiology · 2018Article
- Fungal manipulation of hormone-regulated plant defense.PLoS pathogens · 2017Review
- Phytohormone sensing in the biotrophic fungus Ustilago maydis - the dual role of the transcription factor Rss1.Molecular microbiology · 2016Article
- Localization and Transcriptional Responses ofFrontiers in microbiology · 2016Article
- Microbial effectors target multiple steps in the salicylic acid production and signaling pathway.Frontiers in plant science · 2015Review
- Beyond plant defense: insights on the potential of salicylic and methylsalicylic acid to contain growth of the phytopathogen Botrytis cinerea.Frontiers in plant science · 2015Article
- Intervention of Phytohormone Pathways by Pathogen Effectors.The Plant cell · 2014Review
- Over-the-Counter Monocyclic Non-Steroidal Anti-Inflammatory Drugs in Environment-Sources, Risks, Biodegradation.Water, air, and soil pollutionArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The fungal plant pathogen Sclerotinia sclerotiorum was studied to determine its ability to degrade salicylate, an important defense-signaling molecule in plants. S. sclerotiorum D-E7 was grown at 25 °C in an undefined medium (50 ml) containing minerals, 0.1% soytone, 50 mM MES buffer (pH 6.5), 25 mM glucose, and 1 mM salicylate. Glucose, oxalate, and salicylate concentrations were monitored by HPLC. S. sclerotiorum D-E7 was found to be active in salicylate degradation. However, salicylate alone was not growth supportive and, at higher levels (10 mM), inhibited glucose-dependent growth. Biomass formation (130 mg [dry wt] of mycelium per 50 ml of undefined medium), oxalate concentrations (~10 mM), and culture acidification (final culture pH approximated 5) were essentially the same in cultures grown with or without salicylate (1 mM). Time-course analyses revealed that salicylate degradation and glucose consumption were complete after 7 days of incubation and was concomitant with growth. Trace amounts of catechol, a known intermediate of salicylate metabolism, were detected during salicylate degradation. Overall, these results indicated that S. sclerotiorum has the ability to degrade salicylate and that the presence of low levels of salicylate did not affect growth or oxalate production by S. sclerotiorum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.